{"url_path":"/sec/apre/8-k/2026-05-13/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 ****Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1781983/0001104659-26-059734-index.html","accession_number":"0001104659-26-059734","cik":"0001781983","ticker":"APRE","issuer_name":"Aprea Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781983/0001104659-26-059734-index.html","primary_entity_key":"0001781983","primary_entity_name":"Aprea Therapeutics, Inc."},"word_count":35,"has_tables":true,"body_markdown":"**Item 8.01****Other Events.**\n\nOn May 13, 2026, the Company updated its corporate presentation slide deck. A copy of the corporate presentation slide deck is filed as Exhibit 99.2 hereto and incorporated herein by reference.\n\n​"}